WHO prequalifies OraSure Technologies' HCV self-test, extending access for low- and middle-income countries.

WHO has prequalified OraSure Technologies' first hepatitis C virus (HCV) self-test, extending access to testing and diagnosis. The OraQuick HCV self-test, based on the 2017-prequalified OraQuick® HCV Rapid Antibody Test, allows lay users to perform tests themselves. Low- and middle-income countries can now access affordable self-testing options, contributing to WHO's global goal of HCV elimination.

July 10, 2024
3 Articles